{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:20:54Z","timestamp":1791649254262,"version":"4.3.4"},"reference-count":145,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005270","name":"McKnight Foundation","doi-asserted-by":"publisher","award":["DA053558"],"award-info":[{"award-number":["DA053558"]}],"id":[{"id":"10.13039\/100005270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005270","name":"McKnight Foundation","doi-asserted-by":"publisher","award":["GM062754"],"award-info":[{"award-number":["GM062754"]}],"id":[{"id":"10.13039\/100005270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006984","name":"Irma T Hirschl Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006984","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011331","name":"Monique Weill-Caulier Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012643","name":"Edward Mallinckrodt Jr Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000872","name":"McKnight Endowment Fund for Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000879","name":"Alfred P Sloan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["GM133421"],"award-info":[{"award-number":["GM133421"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["GM133504"],"award-info":[{"award-number":["GM133504"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jbc.2023.105176","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T03:51:03Z","timestamp":1692330663000},"page":"105176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular insights into GPCR mechanisms for drugs of abuse"],"prefix":"10.1016","volume":"299","author":[{"given":"Omar B.","family":"Sanchez-Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6575-508X","authenticated-orcid":false,"given":"Gregory","family":"Zilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.105176_bib1","series-title":"Monitoring the Future national survey results on drug use, 1975-2022: Secondary school students. Monitoring the Future Monograph Series","author":"Miech","year":"2023"},{"key":"10.1016\/j.jbc.2023.105176_bib2","series-title":"Drug overdose deaths in the United States, 2001-2021. NCHS Data Brief, no 457","author":"Spencer","year":"2022"},{"key":"10.1016\/j.jbc.2023.105176_bib3","series-title":"Wide-ranging online data for epidemiologic research (WONDER)","year":"2022"},{"key":"10.1016\/j.jbc.2023.105176_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/187152708786927877","article-title":"Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse","volume":"7","author":"Zhu","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jbc.2023.105176_bib5","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1016\/j.cell.2022.09.041","article-title":"Molecular recognition of morphine and fentanyl by the human mu-opioid receptor","volume":"185","author":"Zhuang","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.38.1.179","article-title":"Cannabinoid receptors and their endogenous agonists","volume":"38","author":"Felder","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2023.105176_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jbc.2023.105176_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.tcb.2020.06.002","article-title":"Conformational basis of G protein-coupled receptor signaling versatility","volume":"30","author":"Wingler","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat7650","article-title":"Manifold roles of beta-arrestins in GPCR signaling elucidated with siRNA and CRISPR\/Cas9","volume":"11","author":"Luttrell","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2023.105176_bib10","article-title":"Genetic evidence that beta-arrestins are dispensable for the initiation of beta(2)-adrenergic receptor signaling to ERK","volume":"10","author":"O'Hayre","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2023.105176_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41467-017-02661-3","article-title":"Lack of beta-arrestin signaling in the absence of active G proteins","volume":"9","author":"Grundmann","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105176_bib12","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1042\/BST20210431","article-title":"Structure determination of GPCRs: cryo-EM compared with X-ray crystallography","volume":"49","author":"Garcia-Nafria","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.jbc.2023.105176_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.026","article-title":"Long-term use of hydrocodone vs. oxycodone in primary care","volume":"205","author":"Harris","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jbc.2023.105176_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/acem.14446","article-title":"Fentanyl versus placebo with ketamine and rocuronium for patients undergoing rapid sequence intubation in the emergency department: the FAKT study-A randomized clinical trial","volume":"29","author":"Ferguson","year":"2022","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.jbc.2023.105176_bib15","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.metabol.2010.07.010","article-title":"Opioids for cancer pain: the challenge of optimizing treatment","volume":"59","author":"Plante","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.jbc.2023.105176_bib16","first-page":"1487","article-title":"Vital Signs: Overdoses of Prescription Opioid Pain Relievers --- United States, 1999--2008","volume":"1","author":"Paulozzi","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jbc.2023.105176_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108832","article-title":"Adapting methadone inductions to the fentanyl era","volume":"141","author":"Buresh","year":"2022","journal-title":"J.\u00a0Subst. Abuse Treat."},{"key":"10.1016\/j.jbc.2023.105176_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1151\/spp021113","article-title":"The neurobiology of opioid dependence: implications for treatment","volume":"1","author":"Kosten","year":"2002","journal-title":"Sci. Pract. Perspect."},{"key":"10.1016\/j.jbc.2023.105176_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.67523","article-title":"Dual mechanisms of opioid-induced respiratory depression in the inspiratory rhythm-generating network","volume":"10","author":"Baertsch","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2023.105176_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopsych.2019.08.028","article-title":"Molecular basis of opioid action: from structures to new leads","volume":"87","author":"Manglik","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib22","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev-biochem-061620-044044","article-title":"Structural insights accelerate the discovery of opioid alternatives","volume":"90","author":"Che","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2023.105176_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2202-12-41","article-title":"GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain","volume":"12","author":"Hahm","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2004.08.012","article-title":"Opioids: cellular mechanisms of tolerance and physical dependence","volume":"5","author":"Bailey","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pharmthera.2008.11.005","article-title":"Physiological and pharmacological implications of beta-arrestin regulation","volume":"121","author":"Schmid","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2023.105176_bib27","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of beta-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib28","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature10954","article-title":"Crystal structure of the micro-opioid receptor bound to a morphinan antagonist","volume":"485","author":"Manglik","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib30","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105176_bib31","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","article-title":"Structure-function of the G protein-coupled receptor superfamily","volume":"53","author":"Katritch","year":"2013","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2023.105176_bib32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib33","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature10361","article-title":"Crystal structure of the beta2 adrenergic receptor-Gs protein complex","volume":"477","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib35","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev-biochem-060614-033910","article-title":"The molecular basis of G protein-coupled receptor activation","volume":"87","author":"Weis","year":"2018","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2023.105176_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into micro-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib37","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature09648","article-title":"Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor","volume":"469","author":"Rasmussen","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cell.2017.12.011","article-title":"Structure of the nanobody-stabilized active state of the Kappa opioid receptor","volume":"172","author":"Che","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the micro-opioid receptor-G(i) protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib40","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41589-022-01208-y","article-title":"Insights into distinct signaling profiles of the microOR activated by diverse agonists","volume":"19","author":"Qu","year":"2022","journal-title":"Nat. Chem Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4155\/fmc.13.215","article-title":"Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications","volume":"6","author":"Vardanyan","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.jbc.2023.105176_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: a review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"J.\u00a0Neurosci. Rural Pract."},{"key":"10.1016\/j.jbc.2023.105176_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14740338.6.2.125","article-title":"Naloxone treatment in opioid addiction: the risks and benefits","volume":"6","author":"van Dorp","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jbc.2023.105176_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav0320","article-title":"Biased ligands at opioid receptors: current status and future directions","volume":"14","author":"Che","year":"2021","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2023.105176_bib45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu opioids and their receptors: evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jbc.2023.105176_bib46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib47","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105176_bib48","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib50","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the mu-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.jbc.2023.105176_bib51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/papr.12801","article-title":"APOLLO-2: a randomized, placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the mu-opioid receptor, for management of moderate to severe acute pain following abdominoplasty","volume":"19","author":"Singla","year":"2019","journal-title":"Pain Pract."},{"key":"10.1016\/j.jbc.2023.105176_bib52","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2147\/JPR.S171013","article-title":"APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the micro-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy","volume":"12","author":"Viscusi","year":"2019","journal-title":"J.\u00a0Pain Res."},{"key":"10.1016\/j.jbc.2023.105176_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41467-018-08162-1","article-title":"Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects","volume":"10","author":"Kliewer","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105176_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62552","article-title":"ss-arrestin 2 germline knockout does not attenuate opioid respiratory depression","volume":"10","author":"Bachmutsky","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jbc.2023.105176_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz3140","article-title":"Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists","volume":"13","author":"Gillis","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.jbc.2023.105176_bib56","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.tips.2020.09.009","article-title":"Critical assessment of G protein-biased agonism at the mu-opioid receptor","volume":"41","author":"Gillis","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jbc.2023.105176_bib57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.15585\/mmwr.mm6814a2","article-title":"Notes from the field: unintentional drug overdose deaths with kratom detected - 27 states, july 2016-december 2017","volume":"68","author":"Olsen","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jbc.2023.105176_bib58","first-page":"792","article-title":"Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects","volume":"112","author":"Prozialeck","year":"2012","journal-title":"J.\u00a0Am. Osteopath. Assoc."},{"key":"10.1016\/j.jbc.2023.105176_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76119-w","article-title":"Chemical composition and biological effects of kratom (Mitragyna speciosa): in\u00a0vitro studies with implications for efficacy and drug interactions","volume":"10","author":"Todd","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2023.105176_bib60","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1021\/acs.jmedchem.1c01273","article-title":"A\u00a0novel mitragynine analog with low-efficacy mu opioid receptor agonism displays antinociception with attenuated adverse effects","volume":"64","author":"Chakraborty","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2023.105176_bib61","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/bph.14913","article-title":"G\u00a0protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder","volume":"177","author":"Gutridge","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s40429-023-00472-9","article-title":"Receptor selectivity and therapeutic potential of kratom in substance use disorders","volume":"10","author":"Mukhopadhyay","year":"2023","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.jbc.2023.105176_bib63","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of Hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.105176_bib64","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105176_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108626","article-title":"Endocannabinoids, cannabinoids and the regulation of anxiety","volume":"195","author":"Petrie","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jbc.2023.105176_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","article-title":"Cannabinoid receptors as therapeutic targets","volume":"46","author":"Mackie","year":"2006","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2023.105176_bib67","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.323.7303.16","article-title":"Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review","volume":"323","author":"Tramer","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.jbc.2023.105176_bib68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157015906778019527","article-title":"Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes","volume":"4","author":"Manzanares","year":"2006","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00702-019-02132-7","article-title":"Cannabinoid(1) (CB-1) receptor antagonists: a molecular approach to treating acute cannabinoid overdose","volume":"127","author":"Skolnick","year":"2020","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.jbc.2023.105176_bib70","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2023.105176_bib71","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1360-0443.2010.03194.x","article-title":"Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on alcohol and related conditions","volume":"106","author":"Lopez-Quintero","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.jbc.2023.105176_bib73","series-title":"Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57).","year":"2022"},{"key":"10.1016\/j.jbc.2023.105176_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173059","article-title":"Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids","volume":"199","author":"Sholler","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jbc.2023.105176_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.lfs.2005.09.011","article-title":"Chemical constituents of marijuana: the complex mixture of natural cannabinoids","volume":"78","author":"Elsohly","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2023.105176_bib76","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib77","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/FBP.0b013e32835a7c4d","article-title":"Delta(9)-tetrahydrocannabinol acts as a partial agonist\/antagonist in mice","volume":"23","author":"Paronis","year":"2012","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib78","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/acschemneuro.9b00429","article-title":"Do toxic synthetic cannabinoid receptor agonists have signature in\u00a0Vitro activity profiles? a case study of AMB-FUBINACA","volume":"10","author":"Finlay","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib79","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.3390\/cells11203262","article-title":"Neutral CB1 receptor antagonists as pharmacotherapies for substance use disorders: rationale, evidence, and challenge","volume":"11","author":"Soler-Cedeno","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2023.105176_bib80","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1001\/archpsyc.58.4.322","article-title":"Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716","volume":"58","author":"Huestis","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib81","first-page":"75","article-title":"Epidiolex (cannabidiol) primer: frequently asked questions for patients and caregivers","volume":"25","author":"Abu-Sawwa","year":"2020","journal-title":"J.\u00a0Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.jbc.2023.105176_bib82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A\u00a0narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jbc.2023.105176_bib83","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib84","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in\u00a0vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/can.2017.0036","article-title":"An update on non-CB(1), non-CB(2) cannabinoid related G-protein-coupled receptors","volume":"2","author":"Morales","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.jbc.2023.105176_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120596","article-title":"The oncogenic lysophosphatidylinositol (LPI)\/GPR55 signaling","volume":"301","author":"Calvillo-Robledo","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2023.105176_bib87","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105176_bib88","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/7854_2016_60","article-title":"Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites","volume":"32","author":"Tai","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib89","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","article-title":"Crystal structure of the human cannabinoid receptor CB(1)","volume":"167","author":"Hua","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib90","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature20613","article-title":"High-resolution crystal structure of the human CB1 cannabinoid receptor","volume":"540","author":"Shao","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib91","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1111\/bph.15627","article-title":"Molecular basis for ligand modulation of the cannabinoid CB(1) receptor","volume":"179","author":"Ramesh","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib92","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.cell.2020.01.008","article-title":"Activation and signaling mechanism revealed by cannabinoid receptor-G(i) complex structures","volume":"180","author":"Hua","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib93","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","article-title":"Structure of a signaling cannabinoid receptor 1-G protein complex","volume":"176","author":"Krishna Kumar","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib94","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41589-022-01038-y","article-title":"Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1","volume":"18","author":"Yang","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib95","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB(1)","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib96","doi-asserted-by":"crossref","first-page":"48024","DOI":"10.1074\/jbc.M406648200","article-title":"Structural mimicry in class A G protein-coupled receptor rotamer toggle switches: the importance of the F3.36(201)\/W6.48(357) interaction in cannabinoid CB1 receptor activation","volume":"279","author":"McAllister","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105176_bib97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/PMC.S32171","article-title":"The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation","volume":"8","author":"Bow","year":"2016","journal-title":"Perspect. Medicin. Chem."},{"key":"10.1016\/j.jbc.2023.105176_bib98","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.6b00137","article-title":"Pharmacology of valinate and tert-leucinate synthetic cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and their analogues","volume":"7","author":"Banister","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib99","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","article-title":"Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials","volume":"370","author":"Christensen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2023.105176_bib100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S2215-0366(20)30290-X","article-title":"Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial","volume":"7","author":"Freeman","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib101","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","article-title":"Structure of an allosteric modulator bound to the CB1 cannabinoid receptor","volume":"15","author":"Shao","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib102","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/17460441.2016.1245289","article-title":"Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target","volume":"11","author":"Janero","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.jbc.2023.105176_bib103","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41591-022-02169-4","article-title":"Drug scheduling limits access to essential medicines and should be reformed","volume":"29","author":"Marks","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2023.105176_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib105","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2023.105176_bib106","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jbc.2023.105176_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.675768","article-title":"On perception and consciousness in HPPD: a systematic review","volume":"15","author":"Vis","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.878609","article-title":"Hallucinogenic persisting perception disorder: a case series and review of the literature","volume":"13","author":"Ford","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jbc.2023.105176_bib109","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14740338.2022.2063273","article-title":"Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment","volume":"21","author":"Doyle","year":"2022","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.jbc.2023.105176_bib110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.toxlet.2018.07.018","article-title":"Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A","volume":"295","author":"Noble","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jbc.2023.105176_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vascn.2016.07.004","article-title":"An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates","volume":"82","author":"Goodwin","year":"2016","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jbc.2023.105176_bib112","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jbc.2023.105176_bib113","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib114","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2023.105176_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96736-3","article-title":"LSD-stimulated behaviors in mice require beta-arrestin 2 but not beta-arrestin 1","volume":"11","author":"Rodriguiz","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2023.105176_bib116","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib117","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105176_bib119","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A\u00a0non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib120","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT(2A) receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib121","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","article-title":"Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale","volume":"51","author":"Strassman","year":"1994","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib122","article-title":"Receptor interaction profiles of 4-alkoxy-3,5-dimethoxy-phenethylamines (mescaline derivatives) and related amphetamines","volume":"12","author":"Kolaczynska","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib123","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41586-021-03376-8","article-title":"Structural insights into the lipid and ligand regulation of serotonin receptors","volume":"592","author":"Xu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib124","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41586-018-0241-9","article-title":"Cryo-EM structure of the serotonin 5-HT(1B) receptor coupled to heterotrimeric G(o)","volume":"558","author":"Garcia-Nafria","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib125","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41422-021-00527-4","article-title":"Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT(1F)-G protein complex","volume":"31","author":"Huang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2023.105176_bib126","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41594-018-0116-7","article-title":"Structural determinants of 5-HT(2B) receptor activation and biased agonism","volume":"25","author":"McCorvy","year":"2018","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib127","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","article-title":"5-HT(2C) receptor structures reveal the structural basis of GPCR polypharmacology","volume":"172","author":"Peng","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib128","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1016\/j.molcel.2022.05.031","article-title":"GPCRs steer G(i) and G(s) selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors","volume":"82","author":"Huang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105176_bib129","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41421-022-00412-3","article-title":"Structural insights into the ligand binding and G(i) coupling of serotonin receptor 5-HT(5A)","volume":"8","author":"Tan","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.jbc.2023.105176_bib130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41594-018-0180-z","article-title":"Structures of the 5-HT(2A) receptor in complex with the antipsychotics risperidone and zotepine","volume":"26","author":"Kimura","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib131","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1232807","article-title":"Structural basis for molecular recognition at serotonin receptors","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105176_bib132","doi-asserted-by":"crossref","first-page":"11443","DOI":"10.1021\/ja105108q","article-title":"Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography","volume":"132","author":"Wacker","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.105176_bib133","doi-asserted-by":"crossref","first-page":"16044","DOI":"10.1021\/ja508394x","article-title":"A\u00a0functional selectivity mechanism at the serotonin-2A GPCR involves ligand-dependent conformations of intracellular loop 2","volume":"136","author":"Perez-Aguilar","year":"2014","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.105176_bib134","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.neuron.2022.08.006","article-title":"Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD","volume":"110","author":"Cao","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2023.105176_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111211","article-title":"Molecular insights into the regulation of constitutive activity by RNA editing of 5HT(2C) serotonin receptors","volume":"40","author":"Gumpper","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2023.105176_bib136","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.biochem.0c00263","article-title":"A\u00a0novel cryo-EM structure enables development of selective cannabinoid receptor drugs","volume":"59","author":"Zilberg","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.105176_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111857","article-title":"Virtual screening-driven discovery of dual 5-HT6\/5-HT2A receptor ligands with pro-cognitive properties","volume":"185","author":"Staron","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2023.105176_bib138","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/mol.60.6.1181","article-title":"Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor","volume":"60","author":"Bunzow","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105176_bib139","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/adb.12410","article-title":"A\u00a0partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment","volume":"22","author":"Pei","year":"2017","journal-title":"Addict. Biol."},{"key":"10.1016\/j.jbc.2023.105176_bib140","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.biopsych.2012.05.014","article-title":"Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics","volume":"72","author":"Revel","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jbc.2023.105176_bib141","doi-asserted-by":"crossref","first-page":"14109","DOI":"10.3390\/ijms160614109","article-title":"Novel therapeutic GPCRs for psychiatric disorders","volume":"16","author":"Komatsu","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105176_bib142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bbrc.2017.05.165","article-title":"GPR3 and GPR6, novel molecular targets for cannabidiol","volume":"490","author":"Laun","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2023.105176_bib143","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1073\/pnas.1916132117","article-title":"The habenular G-protein-coupled receptor 151 regulates synaptic plasticity and nicotine intake","volume":"117","author":"Antolin-Fontes","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105176_bib144","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105176_bib145","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1038\/s41380-018-0313-0","article-title":"Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci","volume":"25","author":"Erzurumluoglu","year":"2020","journal-title":"Mol. Psychiatry"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:51:07Z","timestamp":1758243067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823022044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":145,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0021925823022044"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105176","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular insights into GPCR mechanisms for drugs of abuse","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105176"}}